Attached files
| file | filename |
|---|---|
| EX-32.2 - EXHIBIT 32.2 - CROSS COUNTRY HEALTHCARE INC | ccrn20191231-10kex32x2.htm |
| EX-32.1 - EXHIBIT 32.1 - CROSS COUNTRY HEALTHCARE INC | ccrn20191231-10kex32x1.htm |
| EX-31.2 - EXHIBIT 31.2 - CROSS COUNTRY HEALTHCARE INC | ccrn20191231-10kex31x2.htm |
| EX-31.1 - EXHIBIT 31.1 - CROSS COUNTRY HEALTHCARE INC | ccrn20191231-10kex31x1.htm |
| EX-21.1 - EXHIBIT 21.1 - CROSS COUNTRY HEALTHCARE INC | ccrn20191231-10kex21x1.htm |
| EX-14.1 - EXHIBIT 14.1 - CROSS COUNTRY HEALTHCARE INC | ccrn20191231-10kex14x1.htm |
| EX-4.4 - EXHIBIT 4.4 - CROSS COUNTRY HEALTHCARE INC | ccrn20191231-10kex4x4.htm |
| 10-K - 10-K - CROSS COUNTRY HEALTHCARE INC | ccrn20191231-10k.htm |
Exhibit 23.1
CONSENT OF INDEPENDENT REGISTERED PUBLIC ACCOUNTING FIRM
We consent to the incorporation by reference in Registration Statement Nos. 333-145484, 333-188519, 333-196639, and 333-218557 on Form S-8 of our reports dated March 5, 2020, relating to the consolidated financial statements of Cross Country Healthcare, Inc. and subsidiaries, and the effectiveness of Cross Country Healthcare, Inc. and subsidiaries' internal control over financial reporting, appearing in this Annual Report on Form 10-K of Cross Country Healthcare, Inc. for the year ended December 31, 2019.
/s/ Deloitte & Touche LLP |
Boca Raton, Florida
March 5, 2020